Core Viewpoint - Jiangsu Zhonghui Yuantong Biotechnology Co., Ltd. (stock code "Zhonghui Bio", 02627.HK) has experienced a significant decline in its stock price, closing at 44.88 HKD on its fourth trading day, reflecting a drop of 14.02% from its initial offering price [1] Summary by Categories Company Overview - Zhonghui Bio's global offering included a total of 33,442,600 H shares, with 3,996,000 shares allocated for the Hong Kong offering and 29,446,600 shares for international offering [1] Financial Performance - The final offering price was set at 12.90 HKD per share, resulting in total proceeds of 431.4 million HKD. After deducting estimated listing expenses of 48.7 million HKD, the net proceeds amounted to 382.7 million HKD [1] Use of Proceeds - The net proceeds from the global offering will be allocated as follows: approximately 63.6% for the development and registration of core products; about 18.1% for the development and registration of other vaccines in research; around 8.4% for improving processes and commercialization capabilities; approximately 4.9% for the development of technology platforms; and about 5.0% for working capital and other general corporate purposes [1]
中慧生物港股上市第4个交易日跌14%